MAPT and Alzheimer disease: Although the current hypothesis of neurodegeneration in AD is centered around abnormal amyloid and tau aggregation, emerging evidence suggests that endothelial dysfunction is an early and primary event in AD pathogenesis that may precede abnormal protein aggregation and directly contribute to neurodegeneration and synaptic injury.